Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Motegi, T. Ishii, H. Kurosaki, N. Motohashi, K. Yamada, A. Murata, S. Kudoh, K. Kida (Tokyo, Japan). Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD. Eur Respir J 2007; 30: Suppl. 51, 4532

Member's Comments

No comment yet.

Related content which might interest you: Comparison of three different exhaled nitric oxide analyzers in asthma and COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 The relationship between exhaled nitric oxide and airway hyperresponsiveness in patients with asthma Source: Eur Respir J 2007; 30: Suppl. 51, 366s Year: 2007 Investigation of nitric oxide level in the exhaled breath condensate in asthma and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 281s Year: 2005 The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012 The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 281s Year: 2005 The effect of phosphogliv admission on exhaled nitric oxide level in patients with bronchial asthma Source: Annual Congress 2010 - Pharmacological modulation of biomarkers and management Year: 2010 Relationship between exhaled nitric oxide and bronchial hyperreactivity in adult with asthma Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009 Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004 Exhaled nitric oxide and bronchial hyperresponsiveness in steroid-naive patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002 Stability of exhaled nitric oxide (FENO) in patients with severe, steroid-dependent asthma Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 The influence of spirometry on the level of exhaled nitric oxide in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 569s Year: 2003 Using fractional exhaled nitric oxide level to differentiate asthma–COPD overlap syndrome from COPD Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Increased exhaled nitric oxide in nonatopic asthma Source: Annual Congress 2003 - Developments and applications with exhaled breath condensate and exhaled air Year: 2003 Diagnosing asthma using exhaled nitric oxide (eNO) measurements Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 Concentrations of nitric oxide metabolites in the exhaled breath condensate in children with different bronchial asthma control Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Two sites of airway obstruction identified by post-bronchodilation change of exhaled nitric oxide in COPD patients Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019 Year: 2019 Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Changes in nitric oxide production in patients with bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007 Relationship between exhaled nitric oxide (eNO), atopy and asthma in children. ISAAC-clermont-ferrand Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001